Login

Senores Pharmaceuticals Ltd.

₹696.75

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Senores Pharmaceuticals Ltd.

  • NSE : SENORES
Add Alert
Add Watchlist

₹696.75

₹696.75

21.5 (3.18%) - 18 Aug 2025 04:27 PM
  • NSE : SENORES

About Company

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.</p>

Market Cap. ₹ 3,209 Cr.
52 Week - High/Low ₹ 719/435
P/E Ratio 483.26
P/B Ratio 17.87
Enterprise Value ₹ 3,008 Cr.
ROE % 0.79
RSI Value 61.44
EMA 50 618.02
EMA 200 579.28
Market Cap. ₹ 3,209 Cr.
52 Week - High/Low ₹ 719/435
P/E Ratio 43.18
P/B Ratio 14.71
Enterprise Value ₹ 3,073 Cr.
ROE % 26.19
RSI Value 61.44
EMA 50 618.02
EMA 200 579.28
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.